# Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

> **NCT07244510** · PHASE2 · RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Hidradenitis Suppurativa (HS)

## Interventions

- **DRUG:** SCT650C

## Key facts

- **NCT ID:** NCT07244510
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2027-03-12
- **Final completion:** 2028-02-16
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07244510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07244510, "Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07244510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*